Recombinant Human RANTES (rHuRANTES/ CCL5)
CCL5 or RANTES (acronym for Regulated upon Activation, Normal T cell Expressed and presumably Secreted), was initially discovered by subtractive hybridization as a transcript expressed in T cells but not B cells. Eosinophilchemotactic activities released by thrombinstimulated human platelets have also been purified and found to be identical to RANTES. Besides T cells and platelets, RANTES has been reported to be produced by renal tubular epithelium, synovial fibroblasts and selected tumor cells.
Product Specifications
CAS Number
9000-83-3
Endotoxin
Less than 1EU/mg of rHuRANTES/ CCL5 as determined by LAL method.
Purity
>98% by SDS-PAGE and HPLC analyses.
Bioactivity
Reconstitution
Molecular Weight
7.8 kDa, a single non-glycosylated polypeptide chain containing 68 amino acids.
Storage Conditions
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
Lyophilized from a 0.2mm filtered concentrated solution in 20mM PB, pH 7.4, 100mM NaCl.
Host or Source
Escherichia coli.
Recommended Usage
This material is offered by USA Bioworld biotech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. Made in China
AA Sequence
SPYSSDTTPC CFAYIARPLP RAHIKEYFYT SGKCSNPAVV FVTRKNRQVC ANPEKKWVRE YINSLEMS
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human PELO sgRNA gene knockout kit - Lentiviral human PELO sgRNA gene knockout kit (plasmid)
GLRX2 (Glutaredoxin-2, Mitochondrial, Glutaredoxin 2, GRX2, CGI-133, bA101E13.1) (APC)
AKAP12 (A-kinase Anchor Protein 12, AKAP-12, A-kinase Anchor Protein 250kD, AKAP 250, Gravin, Myasthenia Gravis Autoantigen, AKAP250, DKFZp686M0430, DKFZp686O0331, FLJ20945, FLJ97621) (MaxLight 405) discontinued